Tivicay Disease Interactions
There are 3 disease interactions with Tivicay (dolutegravir).
Dolutegravir (applies to Tivicay) hemodialysis
Moderate Potential Hazard, Moderate plausibility.
Dolutegravir has not been studied in patients on dialysis, so caution is recommended if used in these patients.
Dolutegravir (applies to Tivicay) hepatitis
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infectious Hepatitis
Patients with underlying hepatitis B or C may be at increased risk for worsening or development of transaminase elevations with the use of dolutegravir. In some cases there was hepatitis B reactivation particularly in a setting where anti- hepatitis treatment was withdrawn. Appropriate laboratory testing prior to initiating treatment and monitoring for hepatotoxicity during therapy is recommended in patients with underlying hepatitis B or C.
Dolutegravir (applies to Tivicay) liver impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
The effect of severe hepatic impairment (Child - Pugh C) on the pharmacokinetics of dolutegravir has not been studied, therefore dolutegravir is not recommended for use on these patients. No dosage adjustment is needed for patients with mild or moderate hepatic impairment.
Switch to professional interaction data
Tivicay drug interactions
There are 195 drug interactions with Tivicay (dolutegravir).
Tivicay alcohol/food interactions
There are 2 alcohol/food interactions with Tivicay (dolutegravir).
Report options
More about Tivicay (dolutegravir)
- Tivicay consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (19)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: integrase strand transfer inhibitor
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Dovato
Dovato is a complete HIV-1 treatment regimen in one tablet that may be used in adults and children ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Stribild
Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is used to treat HIV-1 infection ...
Epzicom
Epzicom is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Learn ...
Lamivudine
Lamivudine systemic is used for hepatitis b, HIV Infection, nonoccupational exposure, occupational ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
